TrueTicker

NIFTY 50 › Healthcare

Healthcare

Max Healthcare Institute Ltd.

MAXHEALTH on NSE · 19 Nov 2026

NIFTY 50 F&O

1,040.65 ▲ +1.74 % on the day

Overview Quality Outlook Risk & rank Results Accounts Options Guidance & governance

Guidance tracker

What MAXHEALTH guided, and what came next

FiledWhat the filing saysNext results: profit YoYRevenueMove on the day
09 Nov 2026Max Healthcare filed the transcript of its Q2 and H1 FY27 earnings call held on November 3, 2026. Management said Q2 network gross revenue rose 20% year-on-year to INR 3,219 crore, operating EBITDA rose 18% to INR 820 crore with a 26.8% margin, and PAT rose 10% to INR 448 crore. Management said occupancy held at... NSE copy No results filed since
20 Aug 2026Transcript of Max Healthcare's Q1 FY27 earnings call held August 14, 2026, filed under Regulation 30 for the quarter ended June 30, 2026. Management (Chairman and MD Abhay Soi) said Network gross revenue rose 16% year-on-year to INR 2,982 crore and Network operating EBITDA rose 15% to INR 704 crore; operating... NSE copy -15.5 %+20.3 %+1.0 %
13 Aug 2026Max Healthcare filed its Q1 FY27 press release and earnings presentation for the quarter ended June 30, 2026. Gross revenue was ₹2,982 Cr, up 16% YoY; Network Operating EBITDA was ₹704 Cr, up 15% YoY, with margin at 24.8% vs 24.9% in Q1 FY26; Network PAT was ₹357 Cr vs ₹345 Cr in Q1 FY26. The Company completed the... NSE copy -15.5 %+20.3 %+1.0 %
29 May 2026Max Healthcare filed the transcript of its Q4 and FY26 earnings conference call held on May 22, 2026. Management said Q4 network gross revenue was INR 2,664 crore (up 10% YoY) and network operating EBITDA was INR 682 crore (up 8% YoY), with a 26.8% margin; PAT was INR 387 crore. For FY26, network gross revenue was... NSE copy +4.7 %+16.7 %+0.6 %
12 Feb 2026Max Healthcare filed the transcript of its Q3 and 9M FY26 earnings conference call held on February 6, 2026. Management said Network revenue rose 10% year-on-year to INR 2,608 crore in Q3, while operating EBITDA grew 4% to INR 648 crore, with EBITDA margin at 26.1% versus 27.3% a year earlier. Management attributed... NSE copy +7.3 %+12.2 %-6.2 %
07 Feb 2026Max Healthcare filed an investor presentation dated February 7, 2026, for investor conferences, as previously intimated on January 29, 2026. The Chairman and Managing Director and Senior Management will attend the Nuvama India Conference 2026 on February 9, 2026, and the 17th Kotak Chasing Growth Conference 2026 on... NSE copy +7.3 %+12.2 %-6.2 %
21 Nov 2025Transcript of Max Healthcare's Q2 and H1 FY26 earnings call held November 17, 2025, filed under Regulation 30. Management (Abhay Soi) said Q2 network gross revenue rose 21% year-on-year to INR 2,692 crore and network operating EBITDA rose 23% to INR 694 crore, with an EBITDA margin of 26.9%. Q2 PAT was INR 554... NSE copy +26.0 %+10.7 %+1.5 %
19 Nov 2025Max Healthcare Institute filed an updated investor presentation dated November 17, 2025, for use at the Goldman Sachs 14th India CIO Tour on November 20, 2025. The presentation is hosted on the company website, www.maxhealthcare.in. Company states it has 20 facilities with ~5,200 beds currently, 73% of beds in... NSE copy +26.0 %+10.7 %+1.5 %
21 Aug 2025Max Healthcare filed the transcript of its Q1 FY26 earnings conference call held on August 14, 2025, for the quarter ended June 30, 2025. Management said Network gross revenue rose 27% year-on-year to Rs. 2,574 crores and Network operating EBITDA rose 23% to Rs. 613 crores, with the 19th consecutive quarter of... NSE copy +74.3 %+25.1 %+1.7 %
05 Aug 2025Transcript of the 24th Annual General Meeting of Max Healthcare Institute Limited, held on July 30, 2025 through video conference. Chairman and MD Abhay Soi said FY2024-25 was a record year: network gross revenue grew 26% year-on-year to ₹9,065 crore, operating EBITDA rose almost 22% to ₹2,319 crore, and profit... NSE copy +30.3 %+31.4 %+0.5 %
27 May 2025Max Healthcare filed the transcript of its Q4 FY25 earnings call held on May 21, 2025. Q4 FY25 network gross revenue was INR 2,429 crore (up 29% YoY) and network operating EBITDA was INR 632 crore (up 26% YoY) at a 27.2% margin; profit after tax excluding exceptional items and one-off tax gains was INR 376 crore... NSE copy +30.3 %+31.4 %+0.5 %
20 May 2025Max Healthcare filed its press release and presentation on Q4 and FY25 earnings for the quarter and year ended March 31, 2025. Q4 FY25 network gross revenue was INR 2,429 Cr (+29% YoY, +2% QoQ); Network Operating EBITDA was INR 632 Cr (+26% YoY); operating margin was 27.2% vs 28.0% in Q4 FY24; PAT was INR 376 Cr vs... NSE copy +30.3 %+31.4 %+0.5 %
06 Feb 2025Max Healthcare filed the transcript of its Q3 FY25 earnings conference call held on January 31, 2025, covering results for the quarter and nine months ended December 31, 2024. Management said Q3 network gross revenue was Rs. 2,381 crores (up 34% year-on-year) and network operating EBITDA was Rs. 622 crores (up 32%... NSE copy +27.2 %+34.2 %-2.0 %
13 Nov 2024Max Healthcare filed the transcript of its Q2 and H1 FY25 earnings conference call held on November 7, 2024. Management reported Q2 network revenue of Rs. 2,228 crore (up 22% YoY) and operating EBITDA (excluding extraordinary items) of Rs. 591 crore, with a 28.2% margin; PAT excluding extraordinary items was Rs.... NSE copy -17.5 %+40.0 %+1.8 %
27 Sep 2024Max Healthcare filed the transcript of its 23rd Annual General Meeting, held on September 20, 2024 via video conference. Chairman and MD Abhay Soi said the company acquired Alexis Hospital Nagpur and Sahara Hospital Lucknow, adding 750 beds, and that Max Hospital Dwarka (303 beds) started operations in June 2024.... NSE copy +1.9 %+25.3 %+3.4 %
08 Aug 2024Max Healthcare filed the transcript of its Q1 FY25 earnings conference call held on August 2, 2024, for the quarter ended June 30, 2024. Management (Chairman and MD Abhay Soi) reported network gross revenue of Rs. 2,028 crore (up 18% year-on-year) and network operating EBITDA of Rs. 499 crore (up 14% year-on-year),... NSE copy +1.9 %+25.3 %+3.4 %
29 May 2024Max Healthcare filed the transcript of its Q4 and FY24 earnings call held on May 23, 2024. Management said Q4 network gross revenue was Rs. 1,890 crore (up 15% YoY) and network operating EBITDA was Rs. 503 crore (up 15% YoY), with PAT of Rs. 311 crore versus Rs. 320 crore a year earlier. For FY24, management... NSE copy -1.6 %+20.1 %+0.2 %
09 Feb 2024Max Healthcare Institute Limited's board approved a share purchase agreement to acquire 100% equity stake in Alexis Multi-Speciality Hospital Private Limited, which operates a JCI and NABH accredited 200-bedded hospital in Nagpur. The acquisition has an Enterprise Value of INR 412 Crores, per the press release. The... NSE copy -0.1 %+17.2 %+0.4 %
07 Feb 2024Max Healthcare filed the transcript of its Q3 and 9M FY24 earnings call held on February 1, 2024. Management (Abhay Soi, Chairman and MD) said Q3 network gross revenue was Rs. 1,779 crore, up 14% year-on-year, and network operating EBITDA was Rs. 471 crore, up 12% year-on-year; profit after tax was Rs. 338 crore... NSE copy -0.1 %+17.2 %+0.4 %
06 Nov 2023Max Healthcare Institute filed its press release and earnings presentation for the quarter and half year ended September 30, 2023. Q2 FY24 network gross revenue was INR 1,827 Cr, up 17% YoY and 6% QoQ; network operating EBITDA was INR 497 Cr, up 21% YoY, with operating margin of 28.7% versus 27.7% in Q2 FY23. Q2... NSE copy +30.1 %+17.0 %+6.0 %

Filings tagged as guidance, newest first (20 in all), with the company's next results after each: profit and revenue against the same quarter a year before, and the share's move on the results day. Whether the guidance was met is for the reader to judge from both; the site does not score it. The summaries are written by an AI model from the filing and can be wrong - the filing is the source.

Governance

Management, auditors, ratings and legal matters

FiledKindWhat the filing says
09 Nov 2026Legal or regulatoryMax Healthcare filed the transcript of its Q2 and H1 FY27 earnings call held on November 3, 2026. Management said Q2 network gross revenue rose 20% year-on-year to INR 3,219 crore, operating EBITDA rose 18% to INR 820 crore with a 26.8% margin, and PAT rose 10% to INR 448 crore. Management said occupancy held at... NSE copy
30 Oct 2026Management changeBoard of Max Healthcare Institute Limited approved unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2026, with unmodified limited review reports from S.R. Batliboi & Co. LLP. Board approved capex of about ₹93 Crore for redevelopment and clinical capacity... NSE copy
09 Oct 2026Credit ratingCARE Ratings Limited has upgraded the credit ratings of Crosslay Remedies Limited (formerly Jaypee Healthcare Limited), a wholly-owned material subsidiary of the Company. Long term bank facilities of ₹50.00 crore (enhanced from ₹40.00 crore) rated CARE AA+; Stable, reclassified from short term facilities, with... NSE copy
09 Oct 2026Credit ratingCARE Ratings Limited reaffirmed the credit rating of Max Healthcare Institute Limited, as disclosed under Regulation 30 of the SEBI Listing Obligations and Disclosure Requirements Regulations, 2015. Long Term Bank Facilities of ₹1,818.88 Cr (enhanced from ₹1,296.02 Cr) rated CARE AA+; Stable, reaffirmed. Short Term... NSE copy
20 Aug 2026Legal or regulatoryTranscript of Max Healthcare's Q1 FY27 earnings call held August 14, 2026, filed under Regulation 30 for the quarter ended June 30, 2026. Management (Chairman and MD Abhay Soi) said Network gross revenue rose 16% year-on-year to INR 2,982 crore and Network operating EBITDA rose 15% to INR 704 crore; operating... NSE copy
13 Aug 2026Legal or regulatory, Management changeBoard of Max Healthcare Institute Limited approved unaudited standalone and consolidated financial results for the quarter ended June 30, 2026, with unmodified limited review reports from S.R. Batliboi & Co. LLP. Board approved appointment of Mr. Ajay Vij as Director - Chief Supply Chain & Procurement Officer... NSE copy
21 May 2026Legal or regulatory, Management changeMax Healthcare Institute's board, at its meeting on May 21, 2026, approved audited standalone and consolidated results for Q4 and FY ended March 31, 2026, with unmodified auditor's reports from S.R. Batliboi & Co. LLP. Recommended a final dividend of ₹2 per equity share (20% of face value of ₹10), subject to member... NSE copy
08 Apr 2026Management changeBoard of Max Healthcare approved a share purchase agreement to acquire a controlling stake of about 58.39% in Kalinga Hospital Ltd., which operates a 250-bed multi-specialty hospital in Bhubaneswar, Orissa. The Board approved loans up to ₹100 Crore to Kalinga Hospital Ltd. for construction, renovation, upgradation... NSE copy
12 Feb 2026Legal or regulatoryMax Healthcare filed the transcript of its Q3 and 9M FY26 earnings conference call held on February 6, 2026. Management said Network revenue rose 10% year-on-year to INR 2,608 crore in Q3, while operating EBITDA grew 4% to INR 648 crore, with EBITDA margin at 26.1% versus 27.3% a year earlier. Management attributed... NSE copy
05 Feb 2026Legal or regulatoryMax Healthcare filed its Q3 FY26 and nine-month (ended December 31, 2025) earnings press release and presentation. Q3 FY26 network gross revenue was ₹2,608 Cr (+10% YoY); network operating EBITDA was ₹648 Cr (+4% YoY) with a 26.1% margin; network PAT after exceptional items was ₹344 Cr (+9% YoY). Nine-month network... NSE copy
21 Nov 2025Legal or regulatoryTranscript of Max Healthcare's Q2 and H1 FY26 earnings call held November 17, 2025, filed under Regulation 30. Management (Abhay Soi) said Q2 network gross revenue rose 21% year-on-year to INR 2,692 crore and network operating EBITDA rose 23% to INR 694 crore, with an EBITDA margin of 26.9%. Q2 PAT was INR 554... NSE copy
17 Nov 2025Management changeMax Healthcare Institute filed its investor presentation dated November 17, 2025, for investor conferences on November 18, 2025 (CLSA 28th India Forum 2025) and November 20, 2025 (Goldman Sachs 14th India CIO Tour), with the Chairman and Managing Director and senior management participating. The presentation states... NSE copy
14 Nov 2025Legal or regulatoryMax Healthcare filed a press release and presentation on its Q2 FY26 and H1 FY26 results (quarter ended September 30, 2025). Q2 FY26 gross revenue was ₹2,692 Cr (+21% YoY); Network Operating EBITDA was ₹694 Cr (+23% YoY) at a 26.9% margin; Network PAT was ₹554 Cr (+59% YoY), including a one-time favourable tax... NSE copy
02 Oct 2025Credit ratingCARE Ratings reaffirmed Max Healthcare Institute Limited's long-term bank facilities at CARE AA+; Stable (Rs 1,160.38 crore, enhanced from Rs 871.01 crore) and short-term bank facilities at CARE A1+ (Rs 80.00 crore); total facilities Rs 1,240.38 crore. CARE placed the long-term bank facilities of material... NSE copy
20 May 2025Management changeBoard approved audited standalone and consolidated results for FY ended March 31, 2025 and unaudited quarterly results for quarter ended March 31, 2025; auditor Deloitte Haskins & Sells issued unmodified reports. Board recommended a final dividend of ₹1.5 per equity share (15% of face value of ₹10), subject to... NSE copy
01 Apr 2025Credit ratingCARE Ratings Limited reaffirmed the credit rating of Max Healthcare Institute Limited, per a letter dated March 31, 2025, after enhancement of long-term bank facilities by ₹500 Crore. Long-term bank facilities of ₹871.01 Crore (enhanced from ₹371.01 Crore) rated CARE AA+; Stable (Double A Plus; Outlook: Stable),... NSE copy
30 Jan 2025Legal or regulatoryBoard of Max Healthcare Institute Limited approved unaudited standalone and consolidated results for the quarter and nine months ended December 31, 2024; standalone Q3 revenue from operations INR 69,740 lakhs, profit for the period INR 13,824 lakhs. Board approved infusion of up to INR 125 crore by rights... NSE copy
05 Nov 2024Legal or regulatoryMax Healthcare Institute approved unaudited standalone and consolidated results for the quarter and half year ended September 30, 2024, with an unmodified limited review report from Deloitte Haskins & Sells. Standalone Q2 FY25 revenue from operations was INR 68,611 lakhs and total income INR 81,962 lakhs; profit... NSE copy
01 Oct 2024Credit ratingCARE Ratings Limited upgraded long term bank facilities of material subsidiaries Hometrail Buildtech Private Limited and Crosslay Remedies Limited from 'CARE AA; Positive' to 'CARE AA+; Stable'. Hometrail Buildtech: long term bank facilities of ₹87.06 Cr rated CARE AA+; Stable (upgraded); short term bank facilities... NSE copy
30 Sep 2024Credit ratingCARE Ratings Limited upgraded the long term bank facilities of Max Healthcare Institute Limited from 'CARE AA; Positive' to 'CARE AA+; Stable' (letter dated September 30, 2024). CARE reaffirmed the short term bank facilities at 'CARE A1+ (A One Plus)'. Long term bank facilities amount to ₹371.01 Cr and short term... NSE copy

Filings with a management change, a legal or regulatory matter or a credit rating (by their tags), or naming an auditor, a resignation or a pledge of shares; newest first (36 in all). A list of what was filed, not a judgement of the company.

Ask Sensei

Ask Sensei

Ask about any NIFTY 500 company in plain words. The answer comes from its own filings, with the page behind every point.

For example:

See a sample answer

Start free Sign in